July 31- EOD

Well, it was certainly a news filled evening and it will take a couple of days to sort through it all, so today will be a first cut. In general.

July 30th- EOD

While today seemed to have better trading action, the news was actually less interesting than Monday. There are a couple of notes but nothing quite significant. In fact, the most.

July 29- EOD

We finally had a major biotech merger but it was not one that got people excited as volumes and price action in biotech were neutral to negative for most of.

July 26-EOD

It was a relatively quiet day on the news front outside of the hep-C space where there as some news on both VRTX and GILD. Not much happening in the.

July 25- EOD

We had a lot of large cap biotech news in terms of the earnings and I wanted to focus on two of them as both had clean beats but also.

July 24- EOD

The news du jour today was SRPT and I want to focus today’s note entirely on it because there is a lot to talk about. In addition, I want to.

July 23- EOD

We still seem to be in a period of low news flow in terms of biotech stocks, which is fine as it gives me a chance to catch up on.

July 22- EOD

It is more of the same in that the market is a little quiet on news. I expected that there would be something interesting to talk about today but not.

July 19- EOD

Really seemed like a quiet summer day to end the week. Not much to talk about but a couple of follow up notes from earlier discussions. 1. To continue from.

July 18- EOD

Not a ton of news today, so this will be a little bit of a short update but some company specific news with CELG. Outside of that there was the.

July 17- EOD

Well, we finally had a biotech merger but not any of the ones we expected. Outside of the small cap buyout, there was not a lot new today. 1. SPPI.

July 16- EOD

Seemed like a slow news day as the markets pulled back to consolidate some of the recent moves. Biotechs were not immune to the move, although some clearly performed better.

July 15- EOD

Well, there was not a lot of news out there in biotech land but oddly there is a lot I want to talk about and will work through it over.

July 12- EOD

There have been a couple days of biotech buying, especially it seems in the small cap antibiotic space. Outside of the general performance, there has been some significant news. All.

July 10- EOD

Got some interesting news today, which makes this a little more exciting but still not a huge news day (the theme for the week). There will not by a note.

July 9- EOD

Another slow day, although there was some more interesting news. Biotechs continued to underperform the broader market and I suspect that will be a trend for the next couple of.

July 8- EOD

Perhaps we were spoiled last week with the ONXX news but this week seems to be getting off to a slow start. There were some decent sized moves in biotech.

July 2- EOD–> Midday edition

I wanted to follow up on the discussion of yesterday less with an analysis of the potential dance partners for ONXX but more in terms of where do we go.

July 1- EOD

Today was the fallout of the AMGN bid for ONXX. There are a couple of aspects of it that I want to touch on and go a little further than.

June 28- EOD

Not much of a lot of new today but there were some interesting tidbits. 1. BIIB spiked higher today on the back of SNY news. The EMA granted Aubagio exclusivity.

Browsing 20 / 1066 articles